Wall Street Retreats as JPMorgan and Delta Report Earnings

Wall Street experienced a decline on March 7, 2025, as the latest earnings season for major U.S. companies began with mixed results. The S&P 500 index fell by 0.4%, while the Dow Jones Industrial Average dropped 399 points, or 0.8%. The Nasdaq Composite also saw a slight decrease of 0.2%. Both the S&P 500 and Dow recently reached all-time highs, highlighting the pressure on U.S. companies to deliver strong profit growth.

JPMorgan Chase’s earnings report contributed to the downturn. The bank posted profits and revenue that lagged behind analysts’ expectations, leading to a 3.8% decline in its stock price. This shortfall may be partly attributed to analysts not adjusting their forecasts to account for the impact of JPMorgan’s acquisition of the Apple Card credit card portfolio. Despite the disappointing results, CEO Jamie Dimon expressed optimism about the U.S. economy, stating, “consumers continue to spend, and businesses generally remain healthy.”

In a similar vein, Delta Air Lines reported profits that exceeded expectations for the final quarter of 2025, yet its stock fell by 3.3% due to revenue figures that did not meet Wall Street’s forecasts. The midpoint of Delta’s guidance for profits in 2026 also fell short, contributing to investor concerns.

Meanwhile, on the positive side, several healthcare companies saw their stocks rise following positive earnings forecasts shared at an industry conference. Moderna experienced a notable gain of 13.1%, the largest increase in the S&P 500, after announcing that it anticipates revenues for 2025 will surpass previous forecasts. The company also provided updates on various products, including a seasonal flu vaccine that may receive approvals later this year.

Similarly, Revvity saw its stock rise by 2.4% after indicating that its profit for 2025 is expected to exceed initial forecasts. The company also reported that its revenue expectations for the fourth quarter outperformed analysts’ predictions. Outside the healthcare sector, L3Harris Technologies gained 0.4% after announcing plans to spin off its Missile Solutions business through an initial public offering (IPO). The U.S. government has committed to investing $1 billion in the new entity, which will convert to common stock in the IPO, while L3Harris will retain a controlling interest.

The bond market remained relatively stable following the inflation report released on the same day. The report indicated that U.S. consumers experienced an overall price increase of 2.7% compared to the previous year, slightly above the Federal Reserve’s target of 2%. Although this figure raised some concerns, it also suggested that inflation was not accelerating dramatically. Ellen Zentner, chief economic strategist for Morgan Stanley Wealth Management, noted, “We’ve seen this movie before—inflation isn’t reheating, but it remains above target.”

In response to the inflation data, the yield on the 10-year Treasury eased to 4.17% from 4.19%, while the two-year Treasury yield adjusted to 3.52% from 3.54%. This adjustment comes amid speculation that the Federal Reserve may consider reducing its main interest rate at least twice in 2026 to bolster the job market. Lower interest rates could make borrowing more affordable for U.S. households, potentially boosting investment prices, although they could also exacerbate inflation concerns in the long run.

Globally, stock markets displayed mixed results. Japan’s Nikkei 225 index surged by 3.1%, marking one of the most significant increases worldwide, primarily driven by gains in technology stocks. Investors are optimistic about Prime Minister Sanae Takaichi, who assumed office in October, potentially calling for a snap election to reinforce her mandate for increased government spending.

As the earnings season unfolds, investors will continue to scrutinize company reports closely, seeking clarity on the economic outlook and corporate performance amid evolving market conditions.